Aublé advised Generare in its €5 M fundraising with Teampact.ventures, Galion.exe and Vives Partners

French biotech startup Generare has closed a €5 million financing round to accelerate the development of its innovative natural molecule discovery platform. Using cloning and biosynthesis technology, Generare identifies promising compounds produced by micro-organisms, with a view to discovering new antibiotics and cancer treatments.

This round of financing was backed by Teampact.ventures, Galion.exe and Vives Partners, advised by Chammas & Marcheteau.

Thanks to Generare (Dr Vincent Libis and Guillaume Vandenesch) for their trust and collaboration.